- Medicine Name: Voxzogo
- Generic Name: Vosoritide
- Dosage Form & Strength: Injection: 0.4 mg, 0.56 mg, or 1.2 mg lyophilized powder in a single-dose
- Manufactured By: BioMarin Pharmaceutical Inc.
Voxzogo is a C type natriuretic peptide (CNP) analog used to increase linear growth in pediatric patients with achondroplasia who are aged 5 years and older with open epiphyses.
Recommended Dosage: The recommended dosage of Voxzogo injection is based on the patient’s actual body weight. The usual dose is 15 µg/kg body weight, which is administered by subcutaneous injection once daily. Inject doses at around the fixed time each day, if possible. The volume of drug to be administered (injection volume) is based on the patient’s actual body weight and the concentration of reconstituted Voxzogo (0.8 mg/mL or 2 mg/mL). It must be reconstituted prior to administration.
In case a dose is missed, it can be administered within 12 hours of the scheduled time of administration. Beyond 12 hours, skip the missed dose and administer the next daily dose as per the usual dosing schedule.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.